List of Tables
Table 1. Global IL-17 Targeting Biological Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global IL-17 Targeting Biological Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global IL-17 Targeting Biological Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global IL-17 Targeting Biological Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global IL-17 Targeting Biological Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global IL-17 Targeting Biological Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market IL-17 Targeting Biological Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of IL-17 Targeting Biological Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of IL-17 Targeting Biological Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IL-17 Targeting Biological Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on IL-17 Targeting Biological Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IL-17 Targeting Biological Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global IL-17 Targeting Biological Drugs Sales by Region (K Units), 2021–2026
Table 18. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2021–2026)
Table 19. Global IL-17 Targeting Biological Drugs Sales by Region (K Units), 2027–2032
Table 20. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2027–2032)
Table 21. Global IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 27. North America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 28. North America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific IL-17 Targeting Biological Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific IL-17 Targeting Biological Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa IL-17 Targeting Biological Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa IL-17 Targeting Biological Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global IL-17 Targeting Biological Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global IL-17 Targeting Biological Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021–2026)
Table 53. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2027–2032)
Table 54. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global IL-17 Targeting Biological Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global IL-17 Targeting Biological Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2021–2026)
Table 63. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2027–2032)
Table 64. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global IL-17 Targeting Biological Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Chongqing Genrix Biopharmaceutical Company Information
Table 71. Chongqing Genrix Biopharmaceutical Description and Business Overview
Table 72. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product
Table 74. Chongqing Genrix Biopharmaceutical Recent Developments/Updates
Table 75. Jiangsu Hengrui Medicine Company Information
Table 76. Jiangsu Hengrui Medicine Description and Business Overview
Table 77. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product
Table 79. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis IL-17 Targeting Biological Drugs Product
Table 84. Novartis Recent Developments/Updates
Table 85. UCB Company Information
Table 86. UCB Description and Business Overview
Table 87. UCB IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. UCB IL-17 Targeting Biological Drugs Product
Table 89. UCB Recent Developments/Updates
Table 90. Eli Lilly and Co. Company Information
Table 91. Eli Lilly and Co. Description and Business Overview
Table 92. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product
Table 94. Eli Lilly and Co. Recent Developments/Updates
Table 95. Akesobio Company Information
Table 96. Akesobio Description and Business Overview
Table 97. Akesobio IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Akesobio IL-17 Targeting Biological Drugs Product
Table 99. Akesobio Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AstraZeneca IL-17 Targeting Biological Drugs Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. DICE Therapeutics Company Information
Table 106. DICE Therapeutics Description and Business Overview
Table 107. DICE Therapeutics IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. DICE Therapeutics IL-17 Targeting Biological Drugs Product
Table 109. DICE Therapeutics Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. IL-17 Targeting Biological Drugs Distributors List
Table 113. IL-17 Targeting Biological Drugs Customers List
Table 114. IL-17 Targeting Biological Drugs Market Trends
Table 115. IL-17 Targeting Biological Drugs Market Drivers
Table 116. IL-17 Targeting Biological Drugs Market Challenges
Table 117. IL-17 Targeting Biological Drugs Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of IL-17 Targeting Biological Drugs
Figure 2. Global IL-17 Targeting Biological Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global IL-17 Targeting Biological Drugs Market Share by Type: 2025 & 2032
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global IL-17 Targeting Biological Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global IL-17 Targeting Biological Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global IL-17 Targeting Biological Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global IL-17 Targeting Biological Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global IL-17 Targeting Biological Drugs Sales (K Units), 2021–2032
Figure 14. Global IL-17 Targeting Biological Drugs Average Price (US$/Unit), 2021–2032
Figure 15. IL-17 Targeting Biological Drugs Report Years Considered
Figure 16. IL-17 Targeting Biological Drugs Sales Share by Manufacturers in 2025
Figure 17. Global IL-17 Targeting Biological Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global IL-17 Targeting Biological Drugs Players: Market Share by Revenue in IL-17 Targeting Biological Drugs in 2025
Figure 19. IL-17 Targeting Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global IL-17 Targeting Biological Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific IL-17 Targeting Biological Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa IL-17 Targeting Biological Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE IL-17 Targeting Biological Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of IL-17 Targeting Biological Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of IL-17 Targeting Biological Drugs by Type (2021–2032)
Figure 54. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of IL-17 Targeting Biological Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of IL-17 Targeting Biological Drugs by Application (2021–2032)
Figure 57. Global IL-17 Targeting Biological Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. IL-17 Targeting Biological Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
